424B2
Rule 424(b)(2)
Registration No. 333-195373
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
Title of Each Class of Securities Offered |
|
Maximum Aggregate Offering Price |
|
Amount of Registration Fee(1) |
Senior Notes |
|
$250,000,000 |
|
$28,975 |
|
|
(1) |
Calculated in accordance with Rule 457(r) of the Securities Act of 1933. |
PRICING SUPPLEMENT NO. 8 DATED JANUARY 19, 2017
TO PROSPECTUS DATED APRIL 18, 2014, AS SUPPLEMENTED BY
PROSPECTUS SUPPLEMENT DATED APRIL 18, 2014, AND
SUPPLEMENTAL TO THE OFFICERS CERTIFICATE AND COMPANY ORDER DATED APRIL 18, 2014
U.S. BANCORP
Medium-Term
Notes, Series V (Senior)
Medium-Term Notes, Series W (Subordinated)
|
|
|
|
|
CUSIP No.: |
|
|
91159HHQ6 |
|
|
|
Series: |
|
|
|
|
|
☒ Series V (Senior) |
|
☐ Series W (Subordinated) |
|
|
|
Form of Note: |
|
|
|
|
|
☒ Book-Entry |
|
☐ Certificated |
|
|
|
Principal Amount: |
|
|
$250,000,000 |
|
|
|
Trade Date: |
|
|
January 19, 2017 |
|
|
|
Original Issue Date: |
|
|
January 24, 2017 |
|
|
|
Redemption Date: |
|
|
December 23, 2021 |
|
|
|
Maturity Date: |
|
|
January 24, 2022 |
|
|
Base Rate (and, if applicable, related Interest Periods): |
|
|
☐ Fixed Rate Note |
|
☐ Commercial Paper Note |
|
☐ Federal Funds Note |
|
☐ Federal Funds (Effective) Rate |
|
☐ Federal Funds Open Rate |
|
☐ Federal Funds Target Rate |
|
☒ LIBOR Note |
|
☐ EURIBOR Note |
|
☐ Prime Rate Note |
|
☐ CD Rate Note |
|
☐ Treasury Rate Note |
|
☐ CMT Rate Note |
|
☐ Reuters Page FRBCMT |
|
☐ Reuters Page FEDCMT |
|
☐ One-Week ☐ One-Month |
|
☐ Other Base Rate (as described below) |
|
☐ Zero Coupon Note |
|
|
|
Agents Commission: |
|
|
$365,000 |
|
|
Redemption Terms: Redeemable in whole or in part on or after the Redemption Date at 100% of the principal amount of the notes (par), plus accrued and unpaid interest thereon to the date of
redemption. U.S. Bancorp shall provide 10 to 60 calendar days notice of redemption to the registered holder of the note. |
|
|
|
|
Issue Price (Dollar Amount and Percentage of Principal Amount): |
|
|
Amount: |
|
$250,000,000 / 100% |
|
|
Proceeds to the Company: |
|
$249,635,000 |
|
|
Interest Rate/Initial Interest Rate: |
|
LIBOR determined on the Interest Determination Date plus the Spread |
|
|
Interest Payment Dates: |
|
Quarterly, on the 24th of January, April, July and October beginning April 24, 2017 |
|
|
Regular Record Dates: |
|
15 Calendar Days prior to each Interest Payment Date |
|
|
Interest Determination Dates: |
|
2 London business days prior to each Interest Payment Date |
|
|
Interest Reset Dates: |
|
Quarterly, on the 24th of January, April, July and October |
|
|
Index Source: |
|
LIBOR01 (Reuters) |
|
|
Index Maturity: |
|
3 months |
|
|
Spread: |
|
0.64% |
|
|
Spread Multiplier: |
|
Not applicable |
|
|
Maximum Interest Rate: |
|
Maximum rate permitted by New York law |
|
|
Day Count: |
|
Act/360 |
|
|
Minimum Interest Rate: |
|
Not applicable |
|
|
For Original Issue Discount Notes: |
|
|
|
|
Original Issue Discount %: |
|
|
|
|
Yield to Maturity: |
|
|
|
|
Original Issue Discount Notes: |
|
|
☐ |
Subject to special provisions set forth therein with respect to the principal amount thereof payable upon any redemption or acceleration of the maturity thereof. |
☐ |
For Federal income tax purposes only. |
|
|
|
|
|
|
|
|
|
Price to Public |
|
Agents Commissions or Discount |
|
Proceeds to U.S. Bancorp |
Per Note |
|
100% |
|
0.146% |
|
99.854% |
Total |
|
$250,000,000 |
|
$365,000 |
|
$249,635,000 |
|
|
|
|
|
Agent |
|
Principal Amount |
|
U.S. Bancorp Investments, Inc. |
|
|
$83,334,000 |
|
Goldman, Sachs & Co. |
|
|
$83,333,000 |
|
Morgan Stanley & Co. LLC |
|
|
$83,333,000 |
|
Total |
|
|
$250,000,000 |
|
Delivery Instructions: DTC # 0280
|
|
|
/s/ John C. Stern |
|
(authorized officer) |
|
|
/s/ Joseph M. Tessmer |
|
(authorized officer) |
Conflicts of Interest. The issuers affiliate, U.S. Bancorp Investments, Inc., will be
participating in sales of the notes. As such, the offering is being conducted in compliance with the applicable requirements of FINRA Rule 5121.
Notice
to Canadian Investors. The notes are unsecured and are not and will not be savings accounts, deposits, obligations of, or otherwise guaranteed by, U.S. Bank National Association or any other bank. The Notes do not evidence deposits of U.S.
Bank National Association or any other banking affiliate of the Issuer. The notes are not insured by the Federal Deposit Insurance Corporation, the Canada Deposit Insurance Corporation or any other insurer or governmental agency or
instrumentality. U.S. Bancorp is not regulated as a financial institution in Canada. However, U.S. Bank National Associations Canada branch is listed on Schedule III to the Bank Act (Canada) and is subject to regulation by the
Office of the Superintendent of Financial Institutions (Canada). The notes may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus
Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the notes
must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.
Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if the prospectus
(including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchasers province or
territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchasers province or territory for particulars of these rights or consult with a legal advisor.
Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the
disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.